Discovery of cancer biomarkers using antibody arrays

Bibliography

• Pepe MS, Etzioni R, Feng Z, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 2001;93:1054-61
   PubMed Web of Science ®Google Scholar
• Haab BB, Dunham MJ, Brown PO. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2001;2:RESEARCH 0004
   PubMedGoogle Scholar
• Kingsmore SF. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat Rev Drug Discov 2006;5:310-21
   PubMed Web of Science ®Google Scholar
• Chan SM, Ermann J, Su L, et al. Protein microarrays for multiplex analysis of signal transduction pathways. Nat Med 2004;10:1390-6
   PubMed Web of Science ®Google Scholar
• Angenendt P, Glokler J, Murphy D, et al. Toward optimized antibody microarrays: a comparison of current microarray support materials. Anal Biochem 2002;309:253-60
   PubMed Web of Science ®Google Scholar
• Kopf E, Zharhary D. Antibody arrays – an emerging tool in cancer proteomics. Int J Biochem Cell Biol 2007;39:1305-17
   PubMed Web of Science ®Google Scholar
• Sanchez-Carbayo M. Antibody arrays: technical considerations and clinical applications in cancer. Clin Chem 2006;52:1651-9
   PubMed Web of Science ®Google Scholar
• Borrebaeck CA, Wingren C. High-throughput proteomics using antibody microarrays: an update. Expert Rev Mol Diagn 2007;7:673-86
   PubMed Web of Science ®Google Scholar
• Wang X, Yu J, Sreekumar A, et al. Autoantibody signatures in prostate cancer. N Engl J Med 2005;353:1224-35
   PubMed Web of Science ®Google Scholar
• Anderson KS, Labaer J. The sentinel within: exploiting the immune system for cancer biomarkers. J Proteome Res 2005;4:1123-33
   PubMed Web of Science ®Google Scholar
• Nishizuka S, Charboneau L, Young L, et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci USA 2003;100:14229-34
   PubMed Web of Science ®Google Scholar
• Petricoin III EF, Bichsel VE, Calvert VS, et al. Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. J Clin Oncol 2005;23:3614-21
   PubMed Web of Science ®Google Scholar
• Lash GE, Scaife PJ, Innes BA, et al. Comparison of three multiplex cytokine analysis systems: Luminex, SearchLight and FAST Quant. J Immunol Methods 2006;309:205-8
   PubMed Web of Science ®Google Scholar
• De Jager W, Rijkers GT. Solid-phase and bead-based cytokine immunoassay: a comparison. Methods 2006;38:294-303
   PubMed Web of Science ®Google Scholar
• Waterboer T, Sehr P, Pawlita M. Suppression of non-specific binding in serological Luminex assays. J Immunol Methods 2006;309:200-4
   PubMed Web of Science ®Google Scholar
• Belov L, De La Vega O, Dos Remedios CG, Mulligan SP. Immunophenotyping of leukemia using a cluster of differentiation antibody microarray. Cancer Res 2001;61:4483
   PubMed Web of Science ®Google Scholar
• Dotan N, Altstock RT, Schwarz M, Dukler A. Anti-glycan antibodies as biomarkers for diagnosis and prognosis. Lupus 2006;15:442-50
   PubMed Web of Science ®Google Scholar
• Chen S, Laroche T, Hamelinck D, et al. Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays. Nat Methods 2007;4:437-44
   PubMed Web of Science ®Google Scholar
• Nettikadan S, Radke K, Johnson J, et al. Detection and quantification of protein biomarkers from fewer than 10 cells. Mol Cell Proteomics 2006;5:895-901
   PubMed Web of Science ®Google Scholar
• Zajac A, Song D, Qian W, Zhukov T. Protein microarrays and quantum dot probes for early cancer detection. Colloids Surf B Biointerfaces 2007;58:309-14
   PubMed Web of Science ®Google Scholar
• Li Y, Lee HJ, Corn RM. Detection of protein biomarkers using RNA aptamer microarrays and enzymatically amplified surface plasmon resonance imaging. Anal Chem 2007;79:1082-8
   PubMed Web of Science ®Google Scholar
• Bock C, Coleman M, Collins B, et al. Photoaptamer arrays applied to multiplexed proteomic analysis. Proteomics 2004;4:609-18
   PubMed Web of Science ®Google Scholar
• Gembitsky DS, Lawlor K, Jacovina A, et al. A prototype antibody microarray platform to monitor changes in protein tyrosine phosphorylation. Mol Cell Proteomics 2004;3:1102-18
   PubMed Web of Science ®Google Scholar
• Ivanov SS, Chung AS, Yuan ZL, et al. Antibodies immobilized as arrays to profile protein post-translational modifications in mammalian cells. Mol Cell Proteomics 2004;3:788-95
   PubMed Web of Science ®Google Scholar
• Lin Y, Huang R, Cao X, et al. Detection of multiple cytokines by protein arrays from cell lysate and tissue lysate. Clin Chem Lab Med 2003;41:139-45
   PubMed Web of Science ®Google Scholar
• Vazquez-Martin A, Colomer R, Menendez JA. Protein array technology to detect HER2 (erbB-2)-induced ‘cytokine signature’ in breast cancer. Eur J Cancer 2007;43:1117-24
   PubMed Web of Science ®Google Scholar
• Lin Y, Huang R, Chen LP, et al. Profiling of cytokine expression by biotin-labeled-based protein arrays. Proteomics 2003;3:1750-7
   PubMed Web of Science ®Google Scholar
• Lin Y, Huang R, Chen L, et al. Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int J Cancer 2004;109:507-15
   PubMed Web of Science ®Google Scholar
• Garcia BH 2nd, Hargrave A, Morgan A, et al. Antibody microarray analysis of inflammatory mediator release by human leukemia T-cells and human non small cell lung cancer cells. J Biomol Tech 2007;18:245-51
   PubMedGoogle Scholar
• Nielsen UB, Cardone MH, Sinskey AJ, et al. Profiling receptor tyrosine kinase activation by using Ab microarrays. Proc Natl Acad Sci USA 2003;100:9330-5
   PubMed Web of Science ®Google Scholar
• Belov L, Mulligan SP, Barber N, et al. Classification of human leukemias and lymphomas using extensive immunophenotypes obtained by cell capture on an antibody microarray. Br J Haematol 2006;135:184-97
   PubMedGoogle Scholar
• Kato K, Ishimuro T, Arima Y, et al. High-throughput immunophenotyping by surface plasmon resonance imaging. Anal Chem 2007;79:8616-23
   PubMed Web of Science ®Google Scholar
• Yeretssian G, Lecocq M, Lebon G, et al. Competition on nitrocellulose-immobilized antibody arrays: from bacterial protein binding assay to protein profiling in breast cancer cells. Mol Cell Proteomics 2005;4:605-17
   PubMed Web of Science ®Google Scholar
• Flores-Delgado G, Liu CW, Sposto R, Berndt N. A limited screen for protein interactions reveals new roles for protein phosphatase 1 in cell cycle control and apoptosis. J Proteome Res 2007;6:1165-75
   PubMed Web of Science ®Google Scholar
• Bartling B, Hofmann HS, Boettger T, et al. Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma. Lung Cancer 2005;49:145-54
   PubMed Web of Science ®Google Scholar
• Hudelist G, Pacher-Zavisin M, Singer CF, et al. Use of high-throughput protein array for profiling of differentially expressed proteins in normal and malignant breast tissue. Breast Cancer Res Treat 2004;86:281-91
   PubMed Web of Science ®Google Scholar
• Ek S, Andreasson U, Hober S, et al. From gene expression analysis to tissue microarrays – a rational approach to identify therapeutic and diagnostic targets in lymphoid malignancies. Mol Cell Proteomics 2006;5:1072-81
   PubMed Web of Science ®Google Scholar
• Uhlen M, Bjorling E, Agaton C, et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 2005;4:1920-32
   PubMed Web of Science ®Google Scholar
• Kellner U, Steinert R, Seibert V, et al. Epithelial cell preparation for proteomic and transcriptomic analysis in human pancreatic tissue. Pathol Res Pract 2004;200:155-63
   PubMed Web of Science ®Google Scholar
• Miller JC, Zhou H, Kwekel J, et al. Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers. Proteomics 2003;3:56-63
   PubMed Web of Science ®Google Scholar
• Schweitzer B, Roberts S, Grimwade B, et al. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat Biotechnol 2002;20:359-65
   PubMed Web of Science ®Google Scholar
• Zhou H, Bouwman K, Schotanus M, et al. Two-color, rolling-circle amplification on antibody microarrays for sensitive, multiplexed serum-protein measurements. Genome Biol 2004;5:R28
   PubMed Web of Science ®Google Scholar
• Shao W, Zhou Z, Laroche I, et al. Optimization of rolling-circle amplified protein microarrays for multiplexed protein profiling. J Biomed Biotechnol 2003;5:299-307
   Google Scholar
• Saviranta P, Okon R, Brinker A, et al. Evaluating sandwich immunoassays in microarray format in terms of the ambient analyte regime. Clin Chem 2004;50:1907-20
   PubMed Web of Science ®Google Scholar
• Huang R, Lin Y, Shi Q, et al. Enhanced protein profiling arrays with ELISA-based amplification for high-throughput molecular changes of tumor patients' plasma. Clin Cancer Res 2004;10:598-609
   PubMed Web of Science ®Google Scholar
• Varnum SM, Woodbury RL, Zangar RC. A protein microarray ELISA for screening biological fluids. Methods Mol Biol 2004;264:161-72
   PubMedGoogle Scholar
• Sanchez-Carbayo M, Socci ND, Lozano JJ, et al. Profiling bladder cancer using targeted antibody arrays. Am J Pathol 2006;168:93-103
   PubMed Web of Science ®Google Scholar
• Celis JE, Moreira JM, Cabezon T, et al. Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial–adipocyte stromal cell interactions. Mol Cell Proteomics 2005;4:492-522
   PubMed Web of Science ®Google Scholar
• Celis JE, Gromov P, Cabezon T, et al. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol Cell Proteomics 2004;3:327-44
   PubMed Web of Science ®Google Scholar
• Romeo MJ, Espina V, Lowenthal M, et al. CSF proteome: a protein repository for potential biomarker identification. Expert Rev Proteomics 2005;2:57-70
   PubMed Web of Science ®Google Scholar
• Shafer MW, Mangold L, Partin AW, Haab BB. Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease. Prostate 2007;67:255-367
   PubMed Web of Science ®Google Scholar
• Rai AJ, Gelfand CA, Haywood BC, et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 2005;5:3262-77
   PubMed Web of Science ®Google Scholar
• States DJ, Omenn GS, Blackwell TW, et al. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat Biotechnol 2006;24:333-8
   PubMed Web of Science ®Google Scholar
• Haab BB. Antibody arrays in cancer research. Mol Cell Proteomics 2005;4:377-83
   PubMed Web of Science ®Google Scholar
• Borrebaeck CA. Antibody microarray-based oncoproteomics. Expert Opin Biol Ther 2006;6:833-8
   PubMed Web of Science ®Google Scholar